West Pharmaceutical Services (WST)

Short-Term Debt

$20.90M

Quarterly · Period ending: · USD

WST logo

WST Short-Term Debt

Latest reported$20.90M
WST Quarterly Short-Term Debt ($4.40M → $20.90M)
High-resolution chart · PNG

WST short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
20,900,000
21,400,000
22,700,000
21,400,000
20,900,000
21,800,000
17,900,000
19,900,000
153,200,000
151,400,000
151,700,000
71,700,000
18,400,000
18,400,000
18,200,000
15,500,000
54,500,000
54,000,000
53,500,000
52,300,000
11,600,000
11,700,000
12,400,000
12,200,000
12,100,000
11,700,000
11,900,000
9,800,000
10,200,000
10,200,000
100,000
0
0
0
0
33,200,000
33,800,000
34,400,000
2,400,000
2,600,000
2,500,000
2,500,000
69,300,000
71,000,000
95,000,000
98,800,000
27,200,000
27,200,000
2,200,000
14,200,000
2,200,000
18,900,000
100,000
1,700,000
32,700,000
39,300,000
89,100,000
86,500,000
50,100,000
54,700,000
6,300,000
6,300,000
300,000
1,400,000
400,000
21,100,000
500,000
4,000,000
3,900,000
3,900,000
3,900,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
600,000
400,000
300,000
400,000
700,000
0
10,000,000
300,000
4,800,000
3,600,000
8,000,000
16,200,000
15,500,000
12,900,000
15,800,000
6,100,000
13,300,000
15,000,000
8,700,000
24,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.